26 May 2016

Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

  1. Welcome and introduction to format of meeting
  2. Apologies
  3. Any other business
  4. Minutes from the last Committee meeting held on Thursday 28 April 2016
  5. Appraisal of osimertinib for treating metastatic EGFR and T790M mutation-positive non-small-cell lung cancer [ID874]
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by the Chair, Professor Gary McVeigh – Part 1 only (open session)
    • 5.3. Presentation by the lead team, Professor David Bowen, Dr Mohit Sharma and Mr Malcolm Oswald – Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only(closed session)
  6. Appraisal of ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer [ID838]
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by the Vice Chair, Dr Lindsay Smith – Part 1 only (open session)
    • 6.3. Presentation by the Vice Chair, Dr Lindsay Smith – Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only(closed session)
  7. Appraisal of dinutuximab for treating high-risk neuroblastoma [ID799]
    • 7.1. Declarations of interest – Part 1 only (open session)
    • 7.2. Introduction by the Chair, Professor Gary McVeigh – Part 1 only (open session)
    • 7.3. Presentation by the Chair, Professor Gary McVeigh – Part 1 AND part 2 (open and closed session)
    • 7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only(closed session)

Date, time and venue of next meeting:

Wednesday 29 June 2016 10:00, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

To print the agenda, please right click and select 'Print' from the menu.

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration isThursday 12 May 2016. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Jon Littler

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk 

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 27 April 2016 to 12 May 2016
Registration is closed.